Active Ingredient: CISATRACURIUM BESYLATE
Proprietary Name: CISATRACURIUM BESYLATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 10MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A203078
Product Number: 002
Approval Date: Dec 18, 2023
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
